mobic and Colitis--Ischemic

mobic has been researched along with Colitis--Ischemic* in 2 studies

Other Studies

2 other study(ies) available for mobic and Colitis--Ischemic

Article	Year
Ischaemic colitis in a patient taking meloxicam. Lancet (London, England), 2001, Mar-03, Volume: 357, Issue:9257 The safety of cyclo-oxygenase 2 (COX-2) preferential inhibitors such as meloxicam is debated. We describe a patient who presented with bloody diarrhoea after 15 mg meloxicam daily for 10 days for osteoarthritis. The endoscopic and histological features were consistent with the diagnosis of ischaemic colitis. Symptoms and endoscopic lesions quickly regressed within 1 week of meloxicam withdrawal. There was no evidence of another cause of colonic ischaemia. We suggest that meloxicam might have intestinal toxic effects when taken in high doses, because of reduced COX-2 selectivity. Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ischemic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Isoenzymes; Meloxicam; Membrane Proteins; Middle Aged; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Thiazines; Thiazoles	2001
Ischaemic colitis and meloxicam. Lancet (London, England), 2001, May-19, Volume: 357, Issue:9268 Topics: Colitis, Ischemic; Dose-Response Relationship, Drug; Humans; Meloxicam; Risk Assessment; Thiazines; Thiazoles	2001

Article

Year

Ischaemic colitis in a patient taking meloxicam.

Lancet (London, England), 2001, Mar-03, Volume: 357, Issue:9257

The safety of cyclo-oxygenase 2 (COX-2) preferential inhibitors such as meloxicam is debated. We describe a patient who presented with bloody diarrhoea after 15 mg meloxicam daily for 10 days for osteoarthritis. The endoscopic and histological features were consistent with the diagnosis of ischaemic colitis. Symptoms and endoscopic lesions quickly regressed within 1 week of meloxicam withdrawal. There was no evidence of another cause of colonic ischaemia. We suggest that meloxicam might have intestinal toxic effects when taken in high doses, because of reduced COX-2 selectivity.

Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ischemic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Isoenzymes; Meloxicam; Membrane Proteins; Middle Aged; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Thiazines; Thiazoles

2001

Ischaemic colitis and meloxicam.

Lancet (London, England), 2001, May-19, Volume: 357, Issue:9268

Topics: Colitis, Ischemic; Dose-Response Relationship, Drug; Humans; Meloxicam; Risk Assessment; Thiazines; Thiazoles

2001